UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 261

Sortiert nach

Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders

Clinical and experimental immunology, 2017-02, Vol.187 (2), p.304-315

2017

Volltextzugriff (PDF)

Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis

Journal of thrombosis and haemostasis, 2014-09, Vol.12 (9), p.1437-1439

2014

Volltextzugriff (PDF)

Local complement activation in aqueous humor in patients with age-related macular degeneration

Eye (London), 2017-05, Vol.31 (5), p.810-813

2017

Volltextzugriff (PDF)

Pulp Progenitor Cell Recruitment is Selectively Guided by a C5a Gradient

Journal of dental research, 2013-06, Vol.92 (6), p.532-539

2013

Volltextzugriff (PDF)

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

Kidney international, 2006-07, Vol.70 (1), p.42-50

2006

Volltextzugriff (PDF)

Complement Profile in Neonates of Different Gestational Ages

Scandinavian journal of immunology, 2014-04, Vol.79 (4), p.276-281

2014

Volltextzugriff (PDF)

Targeting complement in therapy

Immunological reviews, 2001-04, Vol.180 (1), p.177-189

Kirschfink, Michael

2001

Volltextzugriff (PDF)

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

Molecular Immunology, 2003-09, Vol.40 (2), p.109-123

2003

Volltextzugriff (PDF)

Sublytic complement protects prostate cancer cells from tumour necrosis factor‐α‐induced cell death

Clinical and experimental immunology, 2012-08, Vol.169 (2), p.100-108

2012

Volltextzugriff (PDF)

Dissection of CD20 regulation in lymphoma using RNAi

Leukemia, 2016-12, Vol.30 (12), p.2409-2412

2016

Volltextzugriff (PDF)

[OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL

Journal of hypertension, 2016-09, Vol.34 Suppl 2 - ESH 2016 Abstract Book (Supplement 2), p.e79-e80

2016

Volltextzugriff (PDF)

Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro

Current cancer drug targets, 2010-12, Vol.10 (8), p.922

2010

Volltextzugriff (PDF)

Down‐regulation of CD55 and CD46 expression by anti‐sense phosphorothioate oligonucleotides (S‐ODNs) sensitizes tumour cells to complement attack

Clinical and experimental immunology, 2007-12, Vol.150 (3), p.576-584

2007

Volltextzugriff (PDF)

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid

Clinical and experimental immunology, 2003-02, Vol.131 (2), p.254-263

2003

Volltextzugriff (PDF)

Complement activity and regulation in premature, late premature and term neonates

Immunobiology (1979), 2012-11, Vol.217 (11), p.1154-1154

2012

Volltextzugriff (PDF)

Targeted downregulation of mCRPs (CD46, CD55, and CD59) specifically sensitizes transferrin-receptor (CD71) high expressing malignant cells to complement attack

Molecular immunology, 2011-08, Vol.48 (14), p.1676-1676

2011

Volltextzugriff (PDF)

Complement resistance of tumor cells: basal and induced mechanisms

Molecular immunology, 1999-09, Vol.36 (13), p.929-939

1999

Volltextzugriff (PDF)

Specific targeting of anti-CD59 siRNA by Herceptin®-conjugated liposomes improves complement-mediated cytotoxicity of breast carcinoma cells

Molecular immunology, 2009-09, Vol.46 (14), p.2830-2831

2009

Volltextzugriff (PDF)

Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells

Clinical and experimental immunology, 2009-02, Vol.155 (2), p.239-248

2009

Volltextzugriff (PDF)

Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab

Molecular immunology, 2011-08, Vol.48 (14), p.1677-1677

2011

Volltextzugriff (PDF)

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

Expert opinion on pharmacotherapy, 2001-07, Vol.2 (7), p.1073-1083

2001

Volltextzugriff (PDF)

Umsetzung der deutschen Approbationsordnung 2002 im modularen Reformstudiengang Heidelberger Curriculum Medicinale (HeiCuMed)

Zeitschrift für Hochschulentwicklung, 2011-01, Vol.3 (3)

2011

Volltextzugriff (PDF)

The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition

Thrombosis and haemostasis, 2012-12, Vol.108 (6), p.1141

2012

Volltextzugriff (PDF)

Patient‐centred screening for primary immunodeficiency, a multi‐stage diagnostic protocol designed for non‐immunologists: 2011 update

Clinical and experimental immunology, 2012-01, Vol.167 (1), p.108-119

de Vries, E.

2012

Volltextzugriff (PDF)

Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family

Clinical and experimental immunology, 2006-02, Vol.143 (2), p.297-304

2006

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(126)
Humans
(110)
Life Sciences & Biomedicine
(110)
Biological And Medical Sciences
(62)
Immunology
(61)
Complement
(52)
Male
(51)
Medical Sciences
(46)
Animals
(44)
Female
(41)
Complement Activation
(27)
Adult
(24)
Fundamental And Applied Biological Sciences. Psychology
(23)
Child
(18)
Complement Activation - Drug Effects
(17)
Adolescent
(16)
Physical Sciences
(15)
Complement Activation - Immunology
(14)
Middle Aged
(14)
Physics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Monitoring of complement activation biomarkers and eculizumab in complement‐mediated renal disorders

Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis

Local complement activation in aqueous humor in patients with age-related macular degeneration

Pulp Progenitor Cell Recruitment is Selectively Guided by a C5a Gradient

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

Complement Profile in Neonates of Different Gestational Ages

Targeting complement in therapy

Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors

Sublytic complement protects prostate cancer cells from tumour necrosis factor‐α‐induced cell death

Dissection of CD20 regulation in lymphoma using RNAi

[OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL

Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro

Down‐regulation of CD55 and CD46 expression by anti‐sense phosphorothioate oligonucleotides (S‐ODNs) sensitizes tumour cells to complement attack

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid

Complement activity and regulation in premature, late premature and term neonates

Targeted downregulation of mCRPs (CD46, CD55, and CD59) specifically sensitizes transferrin-receptor (CD71) high expressing malignant cells to complement attack

Complement resistance of tumor cells: basal and induced mechanisms

Specific targeting of anti-CD59 siRNA by Herceptin®-conjugated liposomes improves complement-mediated cytotoxicity of breast carcinoma cells

Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells

Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab

C1-inhibitor: an anti-inflammatory reagent with therapeutic potential

Umsetzung der deutschen Approbationsordnung 2002 im modularen Reformstudiengang Heidelberger Curriculum Medicinale (HeiCuMed)

The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition

Patient‐centred screening for primary immunodeficiency, a multi‐stage diagnostic protocol designed for non‐immunologists: 2011 update

Recurrent infections in partial complement factor I deficiency: evaluation of three generations of a Brazilian family

Suchergebnisse filtern